Activation of the cAMP receptor protein (CRP) from Escherichia coli is highly specific to its allosteric ligand, cAMP. Ligands such as adenosine and cGMP, which are structurally similar to cAMP, fail to activate wild-type CRP. However, several cAMP-independent CRP variants (termed CRP*) exist that can be further activated by both adenosine and cGMP, as well as by cAMP. This has remained a puzzle because the substitutions in many of these CRP* variants lie far from the cAMP-binding pocket (>10 Å) and therefore should not directly affect that pocket. Here we show a surprising similarity in the altered ligand specificity of four CRP* variants with a single substitution in D53S, G141K, A144T, or L148K, and we propose a common basis for this phenomenon. The increased active protein population caused by an equilibrium shift in these variants is hypothesized to preferentially stabilize ligand binding. This explanation is completely consistent with the cAMP specificity in the activation of wild-type CRP. The model also predicts that wild-type CRP should be activated even by the lower-affinity ligand, adenosine, which we experimentally confirmed. The study demonstrates that protein equilibrium is an integral factor for ligand specificity in an allosteric protein, in addition to the direct effects of ligand pocket residues.The cyclic AMP (cAMP) receptor protein (CRP) of Escherichia coli is a well-studied global transcriptional regulator whose activation is highly specific to the binding of cAMP (13). In its cAMP-bound form, CRP binds DNA and interacts with RNA polymerase to stimulate transcription of appropriate genes (3, 21). In the absence of cAMP, CRP displays negligible affinity for DNA. The cAMP specificity of wild-type (WT) CRP is consistent with the structure of active CRP, which has been characterized a number of times and shows specific contacts between protein residues and cAMP (27,29,33). CRP is a homodimer in which each subunit contains two domains, the cAMP-binding domain and the DNA-binding domain, separated by a hinge region (27). The structure of the inactive form of CRP has never been determined, so the mechanism of allosteric activation by cAMP is conjectural, but plausible models for the conformational change that cAMP effects have been proposed (29,39).CRP variants have been found that have altered ligand specificity (1,5,9,14,19,23,40). The substitutions in some of these variants lie in the effector-binding pocket itself and presumably alter the specific interactions between CRP and the ligand (23, 40). Other CRP variants are fundamentally different and more difficult to explain. Specifically, there is a subset of ligandindependent (CRP*) variants that have detectable in vivo activity in the absence of cAMP and also altered ligand specificity. In these cases, the mutationally altered sites lie far from the cAMP-binding pocket, and it is therefore surprising that they alter functional properties of the ligands. A well-studied case is that of A144T CRP, which displays not only a significant activation b...